Joy Y. Feng

14.4k citations
67 papers · 6.6k indexed · 6 hit papers · h-index 30
Topics
HIV/AIDS drug development and treatment (32 papers)HIV Research and Treatment (18 papers)SARS-CoV-2 and COVID-19 Research (13 papers)

In The Last Decade

Joy Y. Feng

66 papers receiving 6.5k citations

Hit Papers

Comparative therapeutic efficacy of remdesivir and combin...2018202620202023202020182020202020194008001.2k

Peers

Joy Y. Feng
Comparison fields: 5 of 136
  • Infectious Diseases 5.2k
  • Molecular Biology 1.4k
  • Neurology 860
  • Epidemiology 822
  • Virology 732
Replace Danielle Porter with:
Danielle Porter United States
Guangdi Li China
Tomáš Cihlář United States
Andrew T. McGuire United States
Mohan Somasundaran United States
Thomas C. Greenough United States
Hans Wilhelm Doerr Germany
Dirk Jochmans Belgium
Alexandra Schäfer United States
Adrian S. Ray United States
Joy Y. Feng relative to Danielle Porter United States Danielle Porter's profile →
Citations per field
00.5×1.5×2.4×
Danielle Porter · 1×
Citations per year

Countries citing papers authored by Joy Y. Feng

Since Specialization
Citations

This map shows the geographic impact of Joy Y. Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Y. Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Y. Feng more than expected).

Fields of papers citing papers by Joy Y. Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Y. Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Y. Feng. The network helps show where Joy Y. Feng may publish in the future.

Co-authorship network of co-authors of Joy Y. Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Y. Feng. A scholar is included among the top collaborators of Joy Y. Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Y. Feng. Joy Y. Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 3
4 42
5 11
6 29
7 5
8
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potencybreakdown →
698
9 74
10 117
11
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVbreakdown →
1241
12 254
13 62
14 6
15 27
16 156
17 71
18 18
19 54
20 20

About Joy Y. Feng

Joy Y. Feng is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 67 papers that have together received 6.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (18 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). The work is most often cited by research in Infectious Diseases (5.2k citations), Virology (732 citations) and Neurology (860 citations). Joy Y. Feng has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Danielle Porter, Matthias Götte, Egor P. Tchesnokov, Calvin J. Gordon, Tomáš Cihlář, Timothy P. Sheahan, Ralph S. Baric, Amy Sims, Mark R. Denison and Jason K. Perry. Their work appears in journals such as Nature, Science and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026